Joshua H. Bilenker is CEO & President at Loxo Oncology, Inc. (LOXO). They have made 47 open-market trades across 2 companies since 2001, most recently 2021-02-03.
CIK 0001612312
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $500K since 2021, against 46 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SANA | BUY | 2021-02-03 | 2023-02-17 | $25.00 | $500K | -13.2% | -18.7% | +66.7% |
| LOXO | SELL | 2018-12-11 | 2018-12-12 | $136.72 | $1.0M | -7.2% | +66.7% | N/A |
| LOXO | SELL | 2018-12-10 | 2018-12-12 | $133.61 | $1.0M | -7.2% | +66.7% | N/A |
| LOXO | SELL | 2018-12-10 | 2018-12-12 | $135.47 | $2.7M | -7.2% | +66.7% | N/A |
| LOXO | SELL | 2018-11-27 | 2018-11-28 | $140.13 | $1.2M | -5.4% | -7.5% | N/A |
| LOXO | SELL | 2018-11-26 | 2018-11-28 | $153.37 | $1.4M | -5.4% | -7.5% | N/A |
| LOXO | SELL | 2018-11-26 | 2018-11-28 | $147.26 | $2.9M | -5.4% | -7.5% | N/A |
| LOXO | SELL | 2018-10-04 | 2018-10-05 | $162.56 | $1.6M | +5.9% | +9.5% | -17.5% |
| LOXO | SELL | 2018-10-03 | 2018-10-05 | $168.14 | $1.2M | +5.9% | +9.5% | -17.5% |
| LOXO | SELL | 2018-09-13 | 2018-09-14 | $165.98 | $1.7M | +6.0% | -2.1% | -13.6% |
| LOXO | SELL | 2018-09-12 | 2018-09-14 | $166.34 | $1.6M | +6.0% | -2.1% | -13.6% |
| LOXO | SELL | 2018-09-12 | 2018-09-14 | $166.15 | $5.0M | +6.0% | -2.1% | -13.6% |
| LOXO | SELL | 2018-08-14 | 2018-08-15 | $159.91 | $1.6M | +4.0% | +3.4% | +0.3% |
| LOXO | SELL | 2018-08-13 | 2018-08-15 | $159.21 | $4.6M | +4.0% | +3.4% | +0.3% |
| LOXO | SELL | 2018-08-13 | 2018-08-15 | $158.91 | $1.6M | +4.0% | +3.4% | +0.3% |
| LOXO | SELL | 2018-07-09 | 2018-07-11 | $184.42 | $3.6M | -5.0% | -13.4% | -8.6% |
| LOXO | SELL | 2018-06-20 | 2018-06-21 | $179.30 | $5.1M | -2.1% | -5.0% | -15.3% |
| LOXO | SELL | 2018-06-19 | 2018-06-21 | $177.93 | $5.1M | -2.1% | -5.0% | -15.3% |
| LOXO | SELL | 2018-06-19 | 2018-06-21 | $178.74 | $16.8M | -2.1% | -5.0% | -15.3% |
| LOXO | SELL | 2018-05-15 | 2018-05-16 | $137.58 | $936K | +4.9% | +10.2% | -0.5% |
| LOXO | SELL | 2018-05-14 | 2018-05-16 | $135.55 | $967K | +4.9% | +10.2% | -0.5% |
| LOXO | SELL | 2018-05-14 | 2018-05-16 | $136.63 | $2.9M | +4.9% | +10.2% | -0.5% |
| LOXO | SELL | 2018-04-25 | 2018-04-26 | $130.83 | $968K | -6.8% | +26.4% | +27.3% |
| LOXO | SELL | 2018-04-24 | 2018-04-26 | $131.39 | $985K | -6.8% | +26.4% | +27.3% |
| LOXO | SELL | 2018-04-24 | 2018-04-26 | $131.07 | $2.9M | -6.8% | +26.4% | +27.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.